// App-Quantinova.ai

2370 : ABO Group As a Thrombotic Risk Factor In Children With Acute Lymphoblastic Leukemia: A Retrospective Study Of 523 Pediatric Patients

Researchers

Presenter

  • Terry Mizrahi

Principal Investigators

  • Jean-Marie Leclerc

  • Michele David

  • Thierry Ducruet

  • Nancy Robitaille

Medical Centers

  • Applied Clinical Research Unit, Hospital Sainte-Justine, University of Montreal, Montreal, Canada

  • Hematology-Oncology Division, Charles Bruneau Cancer Center, Sainte-Justine University Hospital, University of Montreal, Montreal, QC, Canada

  • Division of Hematology-oncology, Department of Pediatrics, Hospital Sainte-Justine, University of Montreal, Montreal, Canada

  • Department of Paediatrics, Division of Hematology-Oncology, Sainte-Justine Hospital, Montreal, Canada, QC, Canada

  • Pediatrics - Neonatology, CHU Sainte-Justine - Universite de Montreal, Montreal, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Acute lymphoblastic leukemia

  • Venous thrombosis

  • Pulmonary embolism

  • Mismatch repair deficiency

  • Solid malignancies

  • Lupus

Biomarkers

  • Breakpoint Cluster Region

  • Nucleoside diphosphate kinase A

Drug/Treatment

  • Protein C

  • Grace

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved